Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Sell
24
DHC Quote, Financials, Valuation and Earnings
Last price:
$2.30
Seasonality move
:
2.11%
Day range:
$2.28 - $2.34
52-week range:
$2.13 - $4.24
Dividend yield:
1.76%
P/E ratio:
--
P/S ratio:
0.37x
P/B ratio:
0.27x
Volume:
821.5K
Avg. volume:
1M
1-year change:
-33.91%
Market cap:
$547.7M
Revenue:
$1.4B
EPS (TTM):
-$1.61
Analysts' Opinion
-
Consensus RatingDiversified Healthcare Trust has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Diversified Healthcare Trust has an estimated upside of 54.19% from its current price of $2.30.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $2.30.
Fair Value
-
According to the consensus of 0 analysts, Diversified Healthcare Trust has 54.19% upside to fair value with a price target of -- per share.
DHC vs. S&P 500
-
Over the past 5 trading days, Diversified Healthcare Trust has overperformed the S&P 500 by 4.51% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Diversified Healthcare Trust does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Diversified Healthcare Trust has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Diversified Healthcare Trust reported revenues of $373.6M.
Earnings Growth
-
Diversified Healthcare Trust earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Diversified Healthcare Trust reported earnings per share of -$0.41.
Enterprise value:
3.1B
EV / Invested capital:
--
Price / LTM sales:
0.37x
EV / EBIT:
--
EV / Revenue:
2.10x
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
35.81x
Price / Operating cash flow:
6.26x
Enterprise value / EBITDA:
19.02x
Gross Profit (TTM):
$252.6M
Return On Assets:
-7.15%
Net Income Margin (TTM):
-26.09%
Return On Equity:
-17.17%
Return On Invested Capital:
-7.63%
Operating Margin:
-5.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $1.3B | $1.4B | $1.5B | $356.5M | $373.6M | |
| Gross Profit | $185.8M | $229.8M | $252.6M | $58.1M | $63.9M | |
| Operating Income | -$87.7M | -$59.9M | -$72.3M | -$16.1M | -$18.9M | |
| EBITDA | $877M | $200.5M | $163.5M | $49.6M | $29.4M | |
| Diluted EPS | $1.75 | -$1.07 | -$1.61 | -$0.28 | -$0.41 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $262.7M | $811.4M | $800.8M | $303.7M | $342.6M | |
| Total Assets | $6.5B | $7.1B | $6.1B | $5.5B | $5.3B | |
| Current Liabilities | $61.5M | $847.2M | $732.2M | $482.5M | $25.2M | |
| Total Liabilities | $3.9B | $4.7B | $3.4B | $3.1B | $3.2B | |
| Total Equity | $2.6B | $2.4B | $2.7B | $2.4B | $2B | |
| Total Debt | $2.8B | $3.6B | $3B | $2.8B | $2.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$87.1M | $14.3M | $86.8M | -$14M | $21.1M | |
| Cash From Investing | $749.3M | -$246.9M | -$172.1M | -$60.5M | -$25.2M | |
| Cash From Financing | -$672.9M | -$289.1M | $67.6M | -$3.5M | -$4.6M | |
| Free Cash Flow | -$87.1M | $14.3M | $86.8M | -$14M | $21.1M | |
DHC
Sector
Market Cap
$547.7M
$1.1B
Price % of 52-Week High
53.54%
82.12%
Dividend Yield
1.76%
3.45%
Shareholder Yield
0.11%
3.47%
1-Year Price Total Return
-36.77%
-5.61%
Beta (5-Year)
2.174
0.887
Dividend yield:
1.76%
Annualized payout:
$0.04
Payout ratio:
-2.5%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$2.24
200-day SMA
Sell
Level
$2.92
Bollinger Bands (100)
Sell
Level
2.54 - 3.68
Chaikin Money Flow
Buy
Level
232.7M
20-day SMA
Sell
Level
$2.36
Relative Strength Index (RSI14)
Sell
Level
39.25
ADX Line
Buy
Level
10.01
Williams %R
Neutral
Level
-65.0602
50-day SMA
Sell
Level
$2.66
MACD (12, 26)
Sell
Level
-0.12
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Sell
Level
-176.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.1524)
Sell
CA Score
(Annual)
Level (-0.7329)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.0196)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.
Stock Forecast FAQ
In the current month, DHC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DHC average analyst price target in the past 3 months is --.
-
Where Will Diversified Healthcare Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Diversified Healthcare Trust share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Diversified Healthcare Trust?
Analysts are divided on their view about Diversified Healthcare Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Diversified Healthcare Trust is a Sell and believe this share price will drop from its current level to --.
-
What Is Diversified Healthcare Trust's Price Target?
The price target for Diversified Healthcare Trust over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Diversified Healthcare Trust is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of DHC?
You can purchase shares of Diversified Healthcare Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Diversified Healthcare Trust shares.
-
What Is The Diversified Healthcare Trust Share Price Today?
Diversified Healthcare Trust was last trading at $2.30 per share. This represents the most recent stock quote for Diversified Healthcare Trust. Yesterday, Diversified Healthcare Trust closed at $2.30 per share.
-
How To Buy Diversified Healthcare Trust Stock Online?
In order to purchase Diversified Healthcare Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
47
DRUG alert for Jan 4
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Buy
85
BMA alert for Jan 4
Banco Macro SA [BMA] is up 0.88% over the past day.
Sell
47
AGFY alert for Jan 4
Agrify [AGFY] is down 5.86% over the past day.
